|Articles|June 13, 2017

Does medication really improve outcomes for kids with ADHD? (VIDEO)

For Contemporary Pediatrics, Dr Bobby Lazzara discusses a controversial UK-based study published in JAMA Pediatrics that examined how well pharmacologic interventions for attention-deficit/hyperactivity disorder (ADHD) help education and health outcomes for impacted kids.

For Contemporary Pediatrics, Dr Bobby Lazzara discusses a controversial UK-based study published in JAMA Pediatrics that examined how well pharmacologic interventions for attention-deficit/hyperactivity disorder (ADHD) help education and health outcomes for impacted kids.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe

Related Content

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Does medication really improve outcomes for kids with ADHD? (VIDEO)

Related Content

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease

FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis

New sunscreen ingredient clears FDA for the first time since the 1990s

FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy